Adapting opioid therapy: real-world analysis of switching from methadone to slow-release morphine and back amid COVID-19 supply chain disruptions
A temporary switch to SROM effectively managed methadone supply disruptions by serving as a viable substitute for methadone, causing minimal withdrawal symptoms and maintaining long-term retention. Coordinated clinical monitoring, institutional protocols, and supportive policy measures ensure continuity of care, emphasizing the value of flexible, personalized treatment strategies during crises.
Authors
- Vaida Baltrūnienė (ORCID: https://orcid.org/0000-0002-3145-2662)
- G Likatavicius
- Emilis Subata
- Linas Zdanavičius
- Artūras Barkus
- Aušra Širvinskienė
- Lina Barkienė
- Haris Jakavicius
- Eglė Lydekaitė
Institutions
- Vilnius University (LT)
- Vilnius University of Applied Sciences (LT)
Publication Details
- Journal
- Addiction Science & Clinical Practice
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1186/s13722-025-00622-6
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00